Management of centralised and de-centralised Companion Diagnostic (CDx) testing and global, customised logistics.For example, molecular tests for influenza can detect upper respiratory tract infections in 15 to 30 minutes. Easy transfer of projects via our dedicated project manager between centres of excellence, with a wide service offerings, including immunoassays, molecular diagnostics, histopathology and medical imaging Rapid molecular tests can produce results very quickly.Equipped with the latest technology for molecular diagnostics in Genetics and Cytogenetics (NGS, CGH-array, Sanger-sequencing, fragment analysis by capillary electrophoresis, real time PCR).Six geneticists, two medical geneticists, two onco-haematologists, and teams of highly specialised technicians.Regulatory consultancy in relation to method validation.Expertise in cell-free circulating DNA analysis (NIPT and liquid biopsy).The clinical laboratory requires high standards of reliability diagnostics may require accreditation or fall under medical device regulations. Equipped with the latest technology for molecular diagnostics in Genetics and Cytogenetics (NGS, CGH-array, Sanger-sequencing, fragment analysis by capillary. Miniaturisation into a single handheld device can bring medical diagnostics into the clinic and into the office or home. Simultaneous screening of multiple genomic aberrations like single nucleotide variants (SNPs), insertions/deletions, copy number variations and gene fusions The industrialisation of molecular biology assay tools has made it practical to use them in clinics.Flexibility in the variety of samples types (fresh, frozen, FFPE, fine needle aspirates (FNA), smears, etc).High-throughput DNA sequencing by NGS technology provides a high level of detection sensitivity and confidence.Services within research of mutations associated to genetic diseases or syndromes, pharmacogenetics, oncogenetics, and personalized treatments.Cross-functional collaboration between our high level experts in Lausanne and the GCP (Good clinical practice) team in Copenhagen.Examples include – but are not limited to: In hematologic malignancies, molecular testing of cytology specimens can be extremely useful in the context of tissue-based neoplasms such as lymphomas and myeloid sarcomas when the source of nucleic acids can be limited. Please note that Idylla is currently under development and for research use only.What we offer Unilabs has a broad range of experience in providing services within Molecular Diagnostics.

Idylla covers the entire process from sample preparation to multiplexed real-time PCR amplification and detection in 90 minutes or less ensuring physicians have the right information to make timely, effective clinical treatment decisions.

The fully integrated system has a compact design providing health care practitioners with direct access to assays in a range of applications (Infectious Disease, Oncology and Genetic tests). Idylla TM is a next generation Molecular Diagnostics Platform that allows for testing at the point of impact and eliminates long waiting times or the necessity of outsourcing tests.

Clinical actionable data at the point of impact Turnaround time ranges from several hours for large laboratories to several days for smaller laboratories that need to send the samples to a specialized molecular lab for testing. Testing is generally performed in batches on large, sophisticated instruments. This type of testing requires specialized, labor-intensive and time-consuming steps that can only be performed by very specialized laboratories and highly qualified technicians. Idylla – New generation of molecular diagnostic testingĭiagnostics and management of infectious diseases such as HIV and many other viral and bacterial infections require the use of molecular testing either to determine the presence of a specific pathogen or to quantify the number of particles in a sample.

Molecular diagnostics examples